Actualizaciones sobre Salud Endocrina y Avances en Diabetes

FTC y Endocrine Society

A federal judge blocked the Federal Trade Commission (FTC) from investigating the Endocrine Society and World Professional Association for Transgender Health, which support gender-affirming care in minors. (Reuters via Yahoo! News)

Tzield y la FDA

Sanofi reportedly wants to pull its FDA priority voucher application for teplizumab (Tzield) after the agency’s top regulator overruled a staff recommendation to expand its use in type 1 diabetes. (Fierce Pharma)

Escasez de Parches de Estrógeno

Despite widespread reports of patients being unable to fill prescriptions, the FDA maintains there is no official shortage of estrogen patches. (NBC News)

Tirzepatide y Protección Renal

Tirzepatide (Mounjaro) was associated with greater kidney protection compared with dulaglutide (Trulicity) in patients with type 2 diabetes and atherosclerotic cardiovascular disease, an exploratory analysis of the SURPASS-CVOT trial found. (Lancet Diabetes & Endocrinology)

Contaminantes en Fórmula Infantil

Experts are raising concerns about forever chemicals and phthalates in the U.S. infant formula supply after reviewing FDA data. (The Guardian)

Athletes y Desarrollo Sexual

Serum sample analysis of elite female track and field athletes found a higher prevalence of XY disorders of sex development compared to the general population. (Journal of Clinical Endocrinology & Metabolism)

Amazon Pharmacy y Ozempic

Amazon Pharmacy will offer same-day delivery or kiosk pick-up for oral semaglutide (Ozempic) for type 2 diabetes. (Fierce Healthcare)

Representación de la Menopausia en Televisión

The New York Times reported a cultural shift in how modern television portrays menopause.

Beta Cell-Targeted GLP-1 Gene Therapy

European regulators greenlit the first clinical trial for a beta cell-targeted GLP-1 gene therapy for type 2 diabetes, Fractyl Health announced.

Cirugía Bariátrica y Microbioma

Patients who underwent bariatric surgery showed gut microbiome alterations linked to type 2 diabetes remission, a subanalysis of a randomized trial found. (Nature Metabolism)

Disclaimer: Esta información no debe considerarse como consejo médico. Consulte siempre a un profesional de la salud para obtener diagnósticos y tratamientos adecuados.


Fuente: https://www.medpagetoday.com/endocrinology/generalendocrinology/121228

STAY UPDATED
Keep up with your specialty

Join the doctors who get the most relevant medical news, curated by specialty, every week — no spam, unsubscribe anytime.

Leave a Reply

Your email address will not be published. Required fields are marked *

ALSO READ...

Comité Científico de TheForumMD

Reviewed and approved by Comité Científico de TheForumMD

Cargando